Featured Conference
3rd Annual Phase IV Clinical Trials
January 30 – February 1, 2006 * Marriott Atlanta Marquis, GA, USA
Visit the conference website for more information and to register.
The value and purpose of a Phase IV clinical study is to increase the knowledge surrounding a new drug, tracking side effects, exploring new uses for the therapy as well as garnering a full understanding of the capability and uses of the drug. This conference will address the key challenges associated with conducting a phase iv trial and the various methods and opportunities available for addressing these obstacles.
Key Topics
- Strategies in maintaining regulatory compliance in Phase IV clinical trials
- Reporting data findings in wide-scale post marketing trials
- Federal mandates impacting post marketing research and trials
- Strategies in determining new indications for drugs going to market
- Overcoming disconnect between scientists and clinical operators
Key Speakers
- Roy Baranello, Assistant VP, Regulatory Policy and Operations, WYETH RESEARCH
- Jim Kremidas, Manager, Global Enrollment Optimization, ELI LILLY
- Eleanor S. Segal, MD, FAAFP, VP and Head, Global Drug Safety, ACTELION PHARMACEUTICALS
- Karen Smith MD, PhD, MBA, Head, Post Marketing Clinical Trials, USA, BRISTOL-MYERS SQUIBB.
- David Dworaczyk, PhD, Vice President, Clinical Development, KING PHARMACEUTICALS INC..
Visit the website for a full panel of speakers.
Access Workshops Hosted by:
Outcome
Scirex
Ovation Research Group
Advisory Board
Ron Christensen, CEO, REGISTRAT
Sean Hart, Group President Late Stage, UBC
Rich Gliklich, CEO, Outcome
Raj Tummala, M.D., MBA, Associate Director Neuroscience, Global Medical Affairs, Wyeth Pharmaceuticals
Joan A. Kroll-Chambers, Director of Strategic Marketing & Development, Tufts Center for the Study of Drug Development, Tufts University
Collaborative Sponsors
Dimensional HealthCare
i3 STATPROBE
Outcome
Ovation
Pace, Parexel
Pharmanet
REGISTRAT
Scirex
United BioSource Corporation
Exhibit Sponsor
Ninaza
Media Partners
Pharma Marketing News
PharmaVoice
Thomson Centerwatch
Pharma Company Insight
Visit the conference website for more information and to register.
For more information, please contact:
Keisha Babb
CGI Tower, 3rd Floor
Warrens
St. Michael, Barbados
Tel :1.246.417.5413
Fax :1.888.844.4901
EMail : pharma@marcusevansbb.com
